DFWIX
Price
$14.06
Change
+$0.10 (+0.72%)
Updated
Apr 28 closing price
Net Assets
4.18B
VTSNX
Price
$136.87
Change
+$0.89 (+0.65%)
Updated
Apr 28 closing price
Net Assets
455.42B
Ad is loading...

DFWIX vs VTSNX

Header iconDFWIX vs VTSNX Comparison
Open Charts DFWIX vs VTSNXBanner chart's image
DFA World ex US Core Equity Instl
Price$14.06
Change+$0.10 (+0.72%)
VolumeN/A
Net Assets4.18B
Vanguard Total Intl Stock Index I
Price$136.87
Change+$0.89 (+0.65%)
VolumeN/A
Net Assets455.42B
DFWIX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFWIX vs. VTSNX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFWIX is a Buy and VTSNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 455B vs. DFWIX (4.18B). DFWIX (3.21) and VTSNX (3.14) have matching dividends . DFWIX was incepted earlier than VTSNX: DFWIX (12 years) vs VTSNX (14 years). DFWIX (0.30) is less costly to investors than VTSNX (0.06). DFWIX is a more actively managed with annual turnover of: 18.00 vs. VTSNX (3.00). DFWIX has a lower initial minimum investment than VTSNX: DFWIX (0) vs VTSNX (5000000). DFWIX annual gain was more profitable for investors over the last year : 10.07 vs. VTSNX (7.79). DFWIX return over 5 years is better than : 67.25 vs. VTSNX (43.27).
DFWIXVTSNXDFWIX / VTSNX
Total Expense Ratio0.300.06500%
Annual Report Gross Expense Ratio0.300.06500%
Fund Existence12 years14 years-
Gain YTD8.1637.431110%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.18B455B1%
Annual Yield % from dividends3.213.14102%
Returns for 1 year10.077.79129%
Returns for 3 years23.0116.37141%
Returns for 5 years67.2543.27155%
Returns for 10 years51.3229.50174%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT2.200.09
+4.27%
Inhibikase Therapeutics
HTGC18.090.18
+1.01%
Hercules Capital
CLW24.460.04
+0.16%
Clearwater Paper Corp
CTXR0.84N/A
-0.59%
Citius Pharmaceuticals Inc
RTO22.86-0.17
-0.74%
Rentokil Initial plc